Consultants (Voting)
Victor Santana, M.D., St. Jude Children’s Hospital
Peter Adamson, M.D., Children’s Hospital of Philadelphia
Alice Ettinger, R.N., Association of Pediatric Oncology Nurses
Jerry Finklestein, M.D., University of California, Los Angeles
Patrick C Reynolds, M.D., Los Angeles Children’s Hospital
Robert Nelson, M.D., Ph.D., The Children's Hospital of Philadelphia
Ruth Hoffman, Candlelighters Children’s Foundation (patient rep.)
Nancy Keene, Independent advocate (patient rep.)
Susan Weiner, Ph.D., Children’s Cause (patient rep.)
Guest Speakers (Non-Voting)
Malcolm Smith, M.D., Cancer Treatment & Evaluation Program, National Cancer Institute, NIH
Frank Balis, M.D., National Cancer Institute, NIH
Edward Sausville, M.D., National Cancer Institute, NIH
Barry Anderson, M.D., National Cancer Institute, NIH
Bruce Morland, M.D., United Kingdom Children’s Cancer Group
Dave Poplack, M.D., Texas Children’s Cancer Center & Hematology Service, Baylor University
Peter Houghton, M.D., Dept. Molecular Pharmacology, St. Jude Children's Research Hospital
Susan Blaney, M.D., Texas Children's Hospital
Joachim Boos, M.D., University of Muenster, Germany
Eric Kodish, M.D., Rainbow Center for Pediatric Ethics, Case Western Reserve University
Industry Attendees (Non-Voting)
Judith Ochs, M.D., Astra Zeneca Pharmaceuticals
Anne Hagey, M.D., Abbott Laboratories Global Oncology Development Group
David Emanuel, M.D., Pharmacia
Steven Weitman, M.D., Ilex Oncology Inc.
Wayne Rackoff, M.D., Johnson & Johnson Pharmaceutical Research & Development